Current Neuropharmacology
Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Ranking and Category
-
69th of 261 in
Neurosciences
-
40th of 261 in
Pharmacology & Pharmacy
Contents
Current Neuropharmacology, Volume 7 - Number 2
Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
, 7(2): 77 - 82Erik K. St. Louis, William E. Rosenfeld and Thomas Bramley
DOI: 10.2174/157015909788848866
Transitional Polytherapy: Tricks of the Trade for Monotherapy to Monotherapy AED Conversions
, 7(2): 83 - 95William R. Garnett, Erik K. St. Louis, Thomas R. Henry and Thomas Bramley
DOI: 10.2174/157015909788848884
Monitoring Antiepileptic Drugs: A Level-Headed Approach
, 7(2): 115 - 119Erik K. St. Louis
DOI: 10.2174/157015909788848938
Concerns with AED Conversion: Comparison of Patient and Physician Perspectives
, 7(2): 120 - 124Brien J. Smith, Erik K. St. Louis, John M. Stern, Chad Green and Thomas Bramley
DOI: 10.2174/157015909788848947
The Serotonergic System: Its Role in Pathogenesis and Early Developmental Treatment of Autism
, 7(2): 150 - 157D. I. Zafeiriou, A. Ververi and E. Vargiami
DOI: 10.2174/157015909788848848
  |
Editor-in-Chief
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK
University College London
Institute of Ophthalmology
London EC1V9EL
UK
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current acting Editor-in-Chief since 2003.
Scopus CiteScore Metrics: 4.28
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net